Rapport Therapeutics, Inc. Common Stock (RAPP)

10.27

(0.88%)

Gross Profit Summary of Rapport Therapeutics, Inc. Common Stock

  • Rapport Therapeutics, Inc. Common Stock's latest annual gross profit in 2023 was -112 Thousand USD , down -646.67% from previous year.
  • Rapport Therapeutics, Inc. Common Stock's latest quarterly gross profit in 2024 Q2 was -208 Thousand USD , down -36.84% from previous quarter.
  • Rapport Therapeutics, Inc. Common Stock reported a annual gross profit of -15 Thousand USD in annual gross profit 2022, down 0.0% from previous year.
  • Rapport Therapeutics, Inc. Common Stock reported a quarterly gross profit of -152 Thousand USD for 2024 Q1, down 0.0% from previous quarter.
  • Rapport Therapeutics, Inc. Common Stock reported a quarterly gross profit of -112 Thousand USD for 2023 FY, down -646.67% from previous quarter.

Annual Gross Profit Chart of Rapport Therapeutics, Inc. Common Stock (2023 - 2022)

Historical Annual Gross Profit of Rapport Therapeutics, Inc. Common Stock (2023 - 2022)

Year Gross Profit Gross Profit Growth
2023 -112 Thousand USD -646.67%
2022 -15 Thousand USD 0.0%

Peer Gross Profit Comparison of Rapport Therapeutics, Inc. Common Stock

Name Gross Profit Gross Profit Difference